Inari Raises $208M in Series D Funding
14 May, 2021
– Oxford Endovascular from Oxford develops a micro stent to treat brain aneurysms.
– The company raised $10m in series A funding round.
– The round was led by new investors Vulpes Investment Management, who joined to lead the round and funds from the Additio Investment Group.
– Existing investors Oxford Sciences Innovation PLC, Parkwalk Advisors, Perivoli Innovations, Oxford Investment Consultants, the University of Oxford and private individuals also followed on.